Private Market View

Magnolia Medical Technologies

Seattle, WA · Founded 2006 · Privately Held (backing)

Last price · $/share
Implied valuation
$244.0M
Total raised
$183.9M
Last round
Early Stage VC
Jan 2022

Key facts

  • Magnolia Medical Technologies’s last known valuation is $244.0M (Jan 2025).
  • It has raised $183.9M across 6 recorded rounds; the latest was Early Stage VC ($43.4M) in Jan 2022.
  • Notable investors include Band of Angels, Lauder Partners, RTW Investments, Vivo Capital, HealthQuest Capital22 tracked in total.
  • Magnolia Medical Technologies has filed 10 Form Ds with the SEC since 2011, most recently Jan 2022 ($43.4M sold to 18 investors).
  • Status: Privately Held (backing).
Free account
See the evidence behind this price
  • ·Post-money valuations for all 6 rounds
  • ·The complete investor list — 22 names
  • ·Watchlist + deal alerts for Magnolia Medical Technologies
Create free account
No card required

Funding rounds

6 rounds
Jan 2022Early Stage VC$43.4MSEC filing
Dec 2018Early Stage VC$19.6MSEC filing
Jun 2016Early Stage VC$21.0MSEC filing
Feb 2016Debt$1.4MSEC filing
May 2015Early Stage VC$6.2MSEC filing

About Magnolia Medical Technologies

Developer of a blood-collection system designed to eliminate sepsis misdiagnosis due to the preventable error of false-positive blood culture results caused by contamination. The company's system is pre-assembled and sterile to actively divert and sequester the initial blood that is known to contain contaminants, then blood cultures are collected through an independent, second flow path, creating a closed vein-to-bottle collection system to prevent bypassing diversion, enabling medical professionals to achieve improved outcomes for all patients, reduce hospital costs and battle the global threat of antibiotic resistance.

Sector
Healthcare
HQ
Seattle, WA, United States
Founded
2006
Employees
84
Ownership
Privately Held (backing)
PA Mark — not yet priced

Magnolia Medical Technologies doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.

Pro members can request priority coverage with a 48-hour turnaround.

Recorded secondary trades

No prints on record

No secondary trades in Magnolia Medical Technologies shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.

Pro members can request priority coverage with a 48-hour turnaround.

Institutional fund marks

No fund marks yet

No SEC-registered fund has reported a fair-value mark on Magnolia Medical Technologies in its N-PORT filings yet. We sweep new filings monthly.

Pro members can request priority coverage with a 48-hour turnaround.